Enhancing Anti-CTLA4 Immunology Therapy for Prostate Cancer with Cotargeting Soluble NKG2D Ligand

Project: Research project

Project Details


Specific Aim 1: To evaluate the combined therapy for symptomatic hormone-independent metastatic prostate cancer. Specific Aim 2: To evaluate the synergy of combined therapy in treating primary and non-symptomatic metastatic prostate tumor.
Effective start/end date10/1/1810/31/20


  • U.S. Army Medical Research and Materiel Command (W81XWH-15-1-0406)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.